Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Cash Flow Performance
Strong compound growth.
Left:
||||
Free cash flow yield
Latest
-42.12%
↓ 14% below average
Average (9y)
-36.89%
Historical baseline
Range
High:0.00%
Low:-128.76%
CAGR
+14.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -42.12% | +1.1% |
| 2023 | -42.59% | -258.2% |
| 2022 | -11.89% | - |
| 2021 | 0.00% | +100.0% |
| 2020 | -19.82% | +31.2% |
| 2019 | -28.81% | +32.6% |
| 2018 | -42.74% | +66.8% |
| 2017 | -128.76% | -228.3% |
| 2016 | -39.22% | -202.7% |
| 2015 | -12.95% | - |